Annual Shareholders Equity
$12.74 M
-$34.97 M-73.29%
December 31, 2023
Summary
- As of February 18, 2025, CADL annual stockholders equity is $12.74 million, with the most recent change of -$34.97 million (-73.29%) on December 31, 2023.
- During the last 3 years, CADL annual shareholders equity has risen by +$36.31 million (+154.09%).
- CADL annual shareholders equity is now -80.13% below its all-time high of $64.14 million, reached on December 31, 2021.
Performance
CADL Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
-$15.26 M
-$5.29 M-53.00%
September 30, 2024
Summary
- As of February 18, 2025, CADL quarterly stockholders equity is -$15.26 million, with the most recent change of -$5.29 million (-53.00%) on September 30, 2024.
- Over the past year, CADL quarterly shareholders equity has stayed the same.
- CADL quarterly shareholders equity is now -123.79% below its all-time high of $64.14 million, reached on December 31, 2021.
Performance
CADL Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
CADL Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -73.3% | 0.0% |
| 3 y3 years | +154.1% | 0.0% |
| 5 y5 years | +258.6% | 0.0% |
CADL Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -80.1% | at low | -123.8% | at low |
| 5 y | 5-year | -80.1% | +154.1% | -123.8% | +64.7% |
| alltime | all time | -80.1% | +154.1% | -123.8% | +64.7% |
Candel Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$15.26 M(+53.0%) |
| Jun 2024 | - | -$9.97 M(-266.8%) |
| Mar 2024 | - | $5.98 M(-53.1%) |
| Dec 2023 | $12.74 M(-73.3%) | $12.74 M(-44.6%) |
| Sep 2023 | - | $23.02 M(-25.2%) |
| Jun 2023 | - | $30.77 M(-22.4%) |
| Mar 2023 | - | $39.65 M(-16.9%) |
| Dec 2022 | $47.71 M | $47.71 M(-8.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $52.13 M(-13.2%) |
| Jun 2022 | - | $60.07 M(-5.8%) |
| Mar 2022 | - | $63.76 M(-0.6%) |
| Dec 2021 | $64.14 M(-372.2%) | $64.14 M(+1.8%) |
| Sep 2021 | - | $62.99 M(-245.9%) |
| Jun 2021 | - | -$43.17 M(+57.0%) |
| Mar 2021 | - | -$27.50 M(+16.7%) |
| Dec 2020 | -$23.56 M(+193.1%) | -$23.56 M |
| Dec 2019 | -$8.04 M | - |
FAQ
- What is Candel Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Candel Therapeutics?
- What is Candel Therapeutics annual shareholders equity year-on-year change?
- What is Candel Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Candel Therapeutics?
- What is Candel Therapeutics quarterly shareholders equity year-on-year change?
What is Candel Therapeutics annual stockholders equity?
The current annual shareholders equity of CADL is $12.74 M
What is the all time high annual shareholders equity for Candel Therapeutics?
Candel Therapeutics all-time high annual stockholders equity is $64.14 M
What is Candel Therapeutics annual shareholders equity year-on-year change?
Over the past year, CADL annual stockholders equity has changed by -$34.97 M (-73.29%)
What is Candel Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of CADL is -$15.26 M
What is the all time high quarterly shareholders equity for Candel Therapeutics?
Candel Therapeutics all-time high quarterly stockholders equity is $64.14 M
What is Candel Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, CADL quarterly stockholders equity has changed by $0.00 (0.00%)